Expression of B7-H4 and IDO1 is Associated with Drug Response and Prognosis of High Grade Ovarian Serous Carcinoma

被引：0
|
作者：
Niu, Na [1 ]
Zhong, Yanping [1 ]
Jazaeri, Amir [1 ]
Sood, Anil [1 ]
Liu, Jinsong [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1166
引用
收藏
页码：1114 / 1115
页数：2
相关论文
共 50 条
  • [21] Significance of PD-L1, IDO-1, and B7-H4 expression in lung cancer.
    Schalper, Kurt Alex
    Carvajal-Hausdorf, Daniel E.
    McLaughlin, Joseph Francis
    Altan, Mehmet
    Syrigos, Konstantinos N.
    Herbst, Roy S.
    Rimm, David L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] High grade ovarian serous carcinoma is associated with a significantly greater expression of p16 than low grade serous carcinoma
    O'Neill, Ciaran
    McBride, Hilary A.
    Connolly, Lynette E.
    McCluggage, Glenn
    MODERN PATHOLOGY, 2006, 19 : 100 - 100
  • [23] Circulating B7-H4 in serum predicts prognosis in patients with hepatocellular carcinoma
    Zhang, S. A.
    Wu, Z. X.
    Zhang, X.
    Zeng, Z. Y.
    Li, D. L.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 13041 - 13048
  • [24] Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes
    Sanuki, Fumiaki
    Mikami, Yuka
    Nishimura, Hirotake
    Fujita, Yoshinori
    Monobe, Yasumasa
    Nomura, Tsunehisa
    Taira, Naruto
    Moriya, Takuya
    BREAST CANCER, 2023, 30 (06) : 1041 - 1053
  • [25] Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes
    Fumiaki Sanuki
    Yuka Mikami
    Hirotake Nishimura
    Yoshinori Fujita
    Yasumasa Monobe
    Tsunehisa Nomura
    Naruto Taira
    Takuya Moriya
    Breast Cancer, 2023, 30 : 1041 - 1053
  • [26] Expression of inflammatory biomarkers is associated with prognosis in patients with high-grade serous ovarian cancer
    Brzezinska, Bogna
    Mysona, David
    Richardson, Katherine
    Purohit, Sharad
    Suhner, Jessa
    Vaz, Jennifer
    Johnson, Marian
    Higgins, Robert
    Rungruang, Bunja
    Ghamande, Sharad
    McIndoe, Richard
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S303 - S304
  • [27] VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
    Liju Zong
    Yuncan Zhou
    Ming Zhang
    Jie Chen
    Yang Xiang
    Cancer Immunology, Immunotherapy, 2020, 69 : 33 - 42
  • [28] VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
    Zong, Liju
    Zhou, Yuncan
    Zhang, Ming
    Chen, Jie
    Xiang, Yang
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (01) : 33 - 42
  • [29] Expression of B7-H4 in endometrial cancer and its impact on patients' prognosis
    Gorzelnik, Katarzyna
    Wasaznik-Jedras, Anna
    Wicherek, Lukasz
    Szubert, Sebastian
    GINEKOLOGIA POLSKA, 2024, 95 (04) : 252 - 258
  • [30] Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome
    Karen Gambaro
    Michael CJ Quinn
    Katia Y Cáceres-Gorriti
    Rebecca S Shapiro
    Diane Provencher
    Kurosh Rahimi
    Anne-Marie Mes-Masson
    Patricia N Tonin
    BMC Cancer, 15
12345